ACHAOGEN - ready for a move up

2018年9月4日

ACHAOGEN is a Biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant gram-negative infections.
After a spectacular uptrend from November 2016 to March 2017, the stock paused for a short time and then started a long period of correction.
In fact from May 2017 the stock is in a deep down move composed of 5 waves.
The question to answer is when will this correction end?
Technically we could see a final move towards $4 but I will take the risk to highlight $5 as a probable bottom for Achaogen and closely follow this call.
The behavior of the stock during the last days is pointing to a possible reaction.
I also like the fact that I am starting to see some positive divergences in short term momentum readings together with extremely oversold levels in several time frames.

Note: below you can read the company's latest press release
investors.achaogen.com/news-releases/news-release-details/achaogen-highlights-multiple-plazomicin-presentations-escmidasm

2018年9月5日

交易進行

Above $5.40 ACHAOGEN is a BUY.
Let's see how it reacts.